Fosun Pharma Conducted Human Safety Trials for Pfizer’s mRNA Vaccines in China – Guess How China Responded to the Data?

Share this:

After completing Pfizer’s initial mRNA human safety trials, China banned Pfizer’s mRNA technology for use in Chinese citizens. The FDA authorized Pfizer’s mRNA as safe for U.S. citizens.

May 12, 2023: According to the NIH clinical trial database, Chinese biotech $44-billion giant, Fosun Pharma, conducted the initial Pfizer/BioNTech Phase-1 human safety trials in 144 civilians in China. After Fosun Pharma completed their clinical evaluation of the safety of Pfizer’s mRNA vaccines for human use, China banned Pfizer’s mRNA technology for use in Chinese citizens.

That’s worth repeating.

 

Despite Fosun Pharma’s apparently horrific clinical findings that resulted in the ban of Pfizer’s mRNA technology for use in Chinese citizens, the FDA authorized the use of Pfizer’s mRNA technology as safe for adults and children who were enrolled in global Phase 2/3 trials across the USA, Brazil, Argentina, South Africa, and Turkey. The FDA then authorized and criminally approved the Pfizer/BioNTech mRNA vaccines as safe and effective for the prevention of SARS-CoV-2 infection in American adults and children.

 

Let’s take a closer look at the evidence from the Pfizer/BioNTech FDA documents and NIH database incriminating Pfizer as a guilty party in criminally experimenting on US and global civilians by using known toxic agents and mRNA gene-editing technology devices in their clinical trials and for world wide distribution and use.

2020 mRA Studies Background Information

Many Americans and global citizens were under the impression that the initial safety and dosing studies for Pfizer’s mRNA COVID-19 injections were…

 

Continue reading full story here… 


Share this:
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x
Scroll to Top